Novozymes A/S

Copenhagen Stock Exchange NSIS-B.CO

Novozymes A/S Debt to Equity Ratio for the year ending December 31, 2023: 0.55

Novozymes A/S Debt to Equity Ratio is 0.55 for the year ending December 31, 2023, a 11.78% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Novozymes A/S Debt to Equity Ratio for the year ending December 31, 2022 was 0.49, a 1,114.37% change year over year.
  • Novozymes A/S Debt to Equity Ratio for the year ending December 31, 2021 was 0.04, a -12.30% change year over year.
  • Novozymes A/S Debt to Equity Ratio for the year ending December 31, 2020 was 0.05, a -88.26% change year over year.
  • Novozymes A/S Debt to Equity Ratio for the year ending December 31, 2019 was 0.40, a 38.80% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
Copenhagen Stock Exchange: NSIS-B.CO

Novozymes A/S

CEO Ms. Ester Baiget
IPO Date Nov. 20, 2000
Location Denmark
Headquarters Krogshoejvej 36
Employees 10,452
Sector Health Care
Industries
Description

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S was founded in 1925 and is based in Bagsvaerd, Denmark.

StockViz Staff

January 15, 2025

Any question? Send us an email